a developer of novel antibodies
Industry Biotechnology
A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then DNLI could also see price increases.
Ticker / NAME | Correlation To PRTA | 1D Price Change % | ||
---|---|---|---|---|
PRTA | 100% | -4.63% | ||
DNLI - PRTA | 46% Loosely correlated | +2.78% | ||
XNCR - PRTA | 46% Loosely correlated | -3.14% | ||
NTLA - PRTA | 45% Loosely correlated | -3.65% | ||
BEAM - PRTA | 45% Loosely correlated | -8.55% | ||
RXRX - PRTA | 44% Loosely correlated | -16.62% | ||
More |
Ticker / NAME | Correlation To PRTA | 1D Price Change % |
---|---|---|
PRTA | 100% | -4.63% |
novel medical theme (11 stocks) | 54% Loosely correlated | -0.49% |
drugs theme (265 stocks) | 48% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 47% Loosely correlated | +5.56% |
europe theme (180 stocks) | 37% Loosely correlated | +0.17% |